Revelation Biosciences Wraps Up Successful Phase 1 Clinical Trial of Gemini Vaccine
Thursday, 13 June 2024, 10:32
Revelation Biosciences Wraps Up First Human Phase 1 Clinical Study on Gemini
Revelation Biosciences has completed dosing of its first in human Phase 1 Clinical Study of Gemini, marking a key achievement in the medical research field. The successful completion of the study highlights the company's dedication to advancing healthcare through innovative solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.